Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports

Background When a new drug becomes available, patients and doctors require information on its benefits and harms. In 2011, Germany introduced the early benefit assessment of new drugs through the act on the reform of the market for medicinal products (AMNOG). At market entry, the pharmaceutical comp...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ
Prif Awduron: Köhler, Michael, Haag, Susanne, Biester, Katharina, Brockhaus, Anne Catharina, McGauran, Natalie, Grouven, Ulrich, Kölsch, Heike, Seay, Ulrike, Hörn, Helmut, Moritz, Gregor, Staeck, Kerstin, Wieseler, Beate
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group Ltd. 2015
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4353284/
https://ncbi.nlm.nih.gov/pubmed/25722024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.h796
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg